AG
Artal Group Portfolio holdings
AUM
$930M
1-Year Return
3.57%
This Quarter Return
+22.25%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$4.52B
AUM Growth
+$640M
(+17%)
Cap. Flow
-$931K
Cap. Flow
% of AUM
-0.02%
Top 10 Holdings %
Top 10 Hldgs %
91.49%
Holding
100
New
10
Increased
15
Reduced
23
Closed
3
Top Buys
| 1 |
Goldman Sachs
GS
|
$22.2M |
| 2 |
Neurocrine Biosciences
NBIX
|
$10.4M |
| 3 |
MDCO
Medicines Co
MDCO
|
$9.5M |
| 4 |
Incyte
INCY
|
$9.44M |
| 5 |
Nektar Therapeutics
NKTR
|
$7.82M |
Top Sells
| 1 |
Alibaba
BABA
|
$27M |
| 2 |
ATH
Athene Holding Ltd. Class A Common Shares
ATH
|
$12.4M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$6.81M |
| 4 |
SAGE
Sage Therapeutics
SAGE
|
$6.77M |
| 5 |
ZTO Express
ZTO
|
$6.28M |
Sector Composition
| 1 | Consumer Staples | 44.29% |
| 2 | Healthcare | 31.71% |
| 3 | Consumer Discretionary | 21.77% |
| 4 | Financials | 0.83% |
| 5 | Industrials | 0.15% |
